TSX:MSCL - Post Discussion
Post by
db2067 on Jul 04, 2022 9:44am
Patent
Satellos Co-founder and CSO, Dr. Michael Rudnicki, a co-inventor, noted, "this new patent application represents the culmination of two years of imaginative and detailed scientific effort led by Dr. Kasun Kodippili in my academic lab at OHRI to systematically map regulatory pathways affecting stem cell polarity. The human implications from his findings for treating disease have enormous potential and I wish to congratulate and thank Dr. Kodippili and the rest of our team for this wonderful work."
https://www.bloomberg.com/press-releases/2022-06-29/satellos-bioscience-announces-in-licensing-of-new-patent-application
Be the first to comment on this post